Back to Search
PETER LANGMUIR, MD
MD
Pediatric Hematology & Oncology Physician
NPI: 1295151488Individual
Specialties, Licenses & Credentials
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
MD059042L(PA)
Research & Publications (8)
Baseline vascular endothelial growth factor concentration as a potential predictive marker of benefit from vandetanib in non-small cell lung cancer.
PMID 19447868·Clin Cancer Res·2009
8-other
Phase II study of vandetanib or placebo in small-cell lung cancer patients after complete or partial response to induction chemotherapy with or without radiation therapy: National Cancer Institute of Canada Clinical Trials Group Study BR.20.
PMID 17878480·J Clin Oncol·2007
3-trial
Magnetic resonance imaging measurements of the response of murine and human tumors to the vascular-targeting agent ZD6126.
PMID 15173071·Clin Cancer Res·2004
7-preclinical
Allograft rejection in a new allospecific CD4+ TCR transgenic mouse.
PMID 12694059·Am J Transplant·2003
7-preclinical
Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance.
PMID 12045261·J Clin Invest·2002
7-preclinical
Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question.
PMID 11145675·J Immunol·2001
4-observational
PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells.
PMID 10648399·Blood·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1250 S COLLEGEVILLE RD
COLLEGEVILLE, PA 19426 - Phone
- (215) 805-3112
Quick Facts
- NPI
- 1295151488
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 8
Are you this provider?
Claim Your Profile